Cited by 41Amyotrophic Lateral Sclerosis ResearchAlzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

The Frontotemporal Syndromes of ALS. Clinicopathological Correlates

Strong, Michael Joseph, Yang, Wencheng·2011·Journal of Molecular Neuroscience

Abstract

Amyotrophic lateral sclerosis (ALS) is increasingly recognized to be a syndromic disorder in which the degeneration of motor neurons is frequently accompanied by a range of syndromes reflective of frontotemporal dysfunction, including a behavioural or cognitive syndrome, a dysexecutive syndrome or a frontotemporal dementia. Both sporadic and familial variants of ALS can be affected. The anatomic substrate of each is a frontotemporal lobar degeneration (FTLD) characterized by superficial linear spongiosus, atrophy and neuronal loss, and both astrocytic and neuronal deposition of TDP-43 as pathological inclusions. Largely unrecognized however is the extent of alterations in tau protein metabolism, particularly in cognitively impaired patients (ALSci). This includes hyper-phosphorylation (pThr(175)) and tau phosphatase resistance, increased fibril formation ex vivo of tau isolated from ALSci and tau immunoreactive aggregates in neurons, dystrophic neurites and astrocytes. In this article, we will review the contemporary clinical, genetic and neuropathological characteristics of the frontotemporal syndromes of ALS and propose that as opposed to being a FTLD in which TDP-43 is the primary disease protein (FTLD-TDP) and that the frontotemporal syndromes of ALS represent a hybrid of both TDP-43 and tau pathology.

Integrity signals

Registry

Crossref · 10.1007/s12031-011-9609-0

Cites

82 of 82 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Alteration in tau protein metabolism including hyperphosphorylation, tau phosphatase resistance, and deposition of PHF-tau intracellular aggregates may be found in diseases characterized by abnormal TDP-43 metabolism, such as ALS.

    “There is also evidence that alteration in tau protein metabolism including hyperphosphorylation, tau phosphatase resistance, and deposition of PHF-tau intracellular aggregates may be found in diseases characterized by abnormal TDP-43 metabolism, such as ALS [177].”

    From The neuropathology of sport (2014) · cites this paper as [177]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Strong, M. J., & Yang, W.
Affiliations
Western University (CA)
Corresponding author
Strong, Michael Joseph
Venue
Journal of Molecular Neuroscience
Published
2011-08-02
Volume
45
Issue
3
Pages
648-655
ISSN
  • 0895-8696 (ISSN-L)
  • 1559-1166
OpenAlex
W2055152437
Cited by
41
References
82
Citations by year
2024: 2 · 2022: 1 · 2020: 1 · 2019: 5 · 2017: 3 · 2016: 6 · 2015: 8 · 2014: 4 · 2013: 5 · 2012: 6
FWCI
3.01
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Molecular Neuroscience (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Neurology › Amyotrophic Lateral Sclerosis Research
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
amyotrophic lateral sclerosis, frontotemporal lobar degeneration, TDP-43, tau hyperphosphorylation, frontotemporal dementia, dysexecutive syndrome, behavioral variant frontotemporal dementia, clinicopathological correlation
MeSH terms
Amyotrophic Lateral Sclerosis, DNA-Binding Proteins, Humans, Syndrome, tau Proteins, Frontotemporal Lobar Degeneration

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review